Join to view full profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Champlin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1978 - 1980
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1975 - 1978
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1975
Certifications & Licensure
CA State Medical License 1976 - Present
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2027
GA State Medical License 2023 - 2027
LA State Medical License 2023 - 2027
MS State Medical License 2023 - 2027
TN State Medical License 2023 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
- America's Top Doctors Castle Connolly, 2006-2014
- Top Doctors:SE Texas Castle Connolly, 2013
Clinical Trials
- Bone Marrow Transplantation in Treating Patients With Lymphoma
- Combination Chemotherapy in Treating Patients With Lymphoma Start of enrollment: 1995 Oct 30
- Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia Start of enrollment: 1991 Mar 05
Publications & Presentations
PubMed
- Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage.Roberta S Azevedo, Elias Jabbour, Nitin Jain, Fadi G Haddad, Partow Kebriaei
Leukemia. 2026-09-01 - Phenotype-Specific Associations Between Graft‑Versus‑Host Disease and Post‑Transplant Outcomes.Portia Smallbone, Yosra Aljawai, George Chen, Partow Kebriaei, Betül Oran
Transplantation and Cellular Therapy. 2026-08-10 - Donor-specific HLA mismatch: haploidentical versus 7/8 mismatched unrelated donor hematopoietic cell transplantation with PTCy.Yosra M Aljawai, Kai Cao, Jun Zou, Yudith Carmazzi, Amin Alousi
Bone Marrow Transplantation. 2026-08-01
Journal Articles
- Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction DrugsKrina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature
- Pilot Study Using Post-Transplant Cyclophosphamide (PTCy), Tacrolimus and Mycophenolate GVHD Prophylaxis for Older Patients Receiving 10/10 HLA-Matched Unrelated Donor...Uday R Popat, Amin Alousi, Issa F Khouri, Muzaffar Qazilbash, Richard E Champlin, Partow Kebriaei, Simrit Parmar, Chitra Hosing, Nature
- Impact of a Novel Prognostic Model, Hematopoietic Cell Transplant-Composite Risk (HCT-CR), on Allogeneic Transplant Outcomes in Patients with Acute Myeloid Leukemia an...Uday Popat, Chitra M Hosing, Issa Khouri, Richard Champlin, Simrit Parmar, Partow Kebriaei, Borje S Andersson, Qaiser Bashir, Amin Alousi, Nature
Abstracts/Posters
- Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell TransplantationRichard E. Champlin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell TransplantationRichard E. Champlin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Post-Transplant Cyclophosphamide (PT-Cy) Based Haploidentical Cell Transplantation (Haplo) Versus Rabbit Anti-Thymocyte Globulin (r-ATG) Based HLA Matched Unrelated Do...Richard E. Champlin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Outcome of Autologous Stem Cell Transplantation in Waldenström's Macroglobulinemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation after Double Cord Blood Transplantation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Clinical and Genomic Characteristics in De Novo Blastoid/Pleomorphic (dnMCL) and Transformed Blastoid/Pleomorphic (t-MCL) Mantle Cell Lymphoma (MCL) in the Ibrutinib E...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Big Changes in AML Care as Targeted Therapy Options ExpandOctober 20th, 2025- Cell Therapy Ascends: New Hope for Combating Mantle Cell LymphomaOctober 20th, 2020
- Myelodysplastic Syndrome Survivor: Why I’ve Been Giving My Care Team Sacagawea CoinsJune 18th, 2020
Grant Support
- Improving The Outcomes Of Stem Cell TransplantationNational Heart, Lung, And Blood Institute2011
- The Therapy Of CMLNational Cancer Institute2010–2011
- Novel Strategies For Hematopoietic Transplantation For Chronic Myeloid LeukemiaNational Cancer Institute2010–2011
- AdministrationNational Cancer Institute2010–2011
- Hematopoietic Transplantation For AMLNational Cancer Institute2001–2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
